Fund Holdings — Indaba Capital Management, L.P.

Total Portfolio Value
$207.55M
Total Bought
$123.51M
Total Sold
$0
Net Transaction
+$123.51M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BLUE OWL CAP CORP III02,793,366+2,793,366040,28019.41%+40,280
REVANCE THERAPEUTICS INC000024,03011.58%+24,030
SUMMIT HOTEL PPTYS(INN)0004,24821,96610.58%+17,718
TRAVERE THERAPEUTICS INC000012,8306.18%+12,830
ESPERION THERAPEUTICS INC NE03,000,000+3,000,00006,6003.18%+6,600
IRONWOOD PHARMACEUTICALS INC(IRWD)0007,96113,0356.28%+5,074
ON24 INC
COM
4,240,2564,240,256025,95027,39213.20%+1,442
BANDWIDTH INC(BAND)00031,40732,16815.50%+761
ACCELERATE DIAGNOSTICS INC00012,41012,3435.95%-67
STANDARD BIOTOOLS INC0007,6320—-7,632
XOMETRY INC(XMTR)00018,5510—-18,551
ESPERION THERAPEUTICS INC NE00032,0190—-32,019
EQUITY COMWLTH4,700,0009,550,000+4,850,00093,53016,9048.14%-76,626
Page 1 of 1
Indaba Capital Management, L.P. — 13F Holdings — Q4 2024 | TickerTrail